TNF and inflammatory bowel disease: Currently, IBD is widely treated with 5-aminosalicylic acid, corticosteroids, guanidinopurine and TNF-α blockers (Alexakis et al., 2017); however, the relationship between these drugs and the development and progression of CAC is unclear.